Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
requirements and tickets into well-engineered components (data prep, pipelines, vector stores, prompts/agents, evaluation hooks). Application & Agent Development: Build, maintain, and update programs like LLM
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 21 days ago
neurophysiology and electrophysiology methods, because we want to take advantage of the population selectivity that optical methods allow: we will use viral vectors with gene promoters that target a specific
-
, KY Grade Level 09 Salary Range $21.00-34.29/hour Type of Position Staff Position Time Status Full-Time Required Education HS Click here for more information about equivalencies: https://hr.uky.edu
-
(recombinant viral vectors – AAV, mouse breeding), imaging (histology, light microscopy, confocal microscopy), and strength analyses (whole body plethysmography to evaluate respiration, limb function tests
-
using (ultra) high-throughput screening. The doctoral candidate will: (i) develop host-vector systems for expression of metagenomic libraries at high temperatures; (ii) create metagenomic libraries from
-
Description The Arthropod Disease Vector Biology lab (https://www.imbb.forth.gr/en/research ), headed by Dr. Michail Kotsyfakis, invites applications for one research assistant position to work on the newly
-
equivalencies: https://hr.uky.edu/employment/working-uk/equivalencies Required Related Experience No experience required. Required License/Registration/Certification KY Radiation Operator’s License at time of
-
information about equivalencies: https://hr.uky.edu/employment/working-uk/equivalencies Required Related Experience No experience required. Required License/Registration/Certification KY Radiation Operator’s
-
opportunity Hydrogen (H2) is widely recognised as a clean energy vector essential for decarbonising hard-to-abate sectors. Currently the large-scale deployment of hydrogen remains constrained by the limitations
-
activation, cytotoxicity, and persistence. Additional methods may involve CRISPR-based perturbations, viral vector engineering, and immune cell manufacturing workflows relevant to CAR-based therapies. In vivo